EMA Authorised: DuoTrav (travoprost;timolol) — Novartis Europharm Limited

View source ↗

Summary

The EMA authorised DuoTrav, a fixed-dose combination eye drop of travoprost and timolol by Novartis Europharm Limited, for open-angle glaucoma and ocular hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Status: Authorised. Therapeutic area: Glaucoma, Open-Angle;Ocular Hypertension. MAH: Novartis Europharm Limited. Decision date: 03/02/2026